http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990086030-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate | 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990086030-A |
| titleOfInvention | Monoclonal antibody against human S-100A6 protein, hybridoma cell line, and preparation method thereof |
| abstract | The present invention relates to a monoclonal antibody derived from a mouse having a high binding ability only to human S-100A6 protein specifically expressed in cancer tissues and cancer cells, a hybridoma cell line producing the antibody and a method for producing the cell line.n n n The monoclonal antibody of the present invention specifically binds only to cancer cells present in cancer tissues resected from different cancer patients, thereby distinguishing cancer cells specifically and clearly distinguishing them from normal cells. It works. |
| priorityDate | 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.